X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs STERLING BIOTECH - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA STERLING BIOTECH ABBOTT INDIA/
STERLING BIOTECH
 
P/E (TTM) x 37.8 -0.4 - View Chart
P/BV x 9.8 0.0 68,516.1% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ABBOTT INDIA   STERLING BIOTECH
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
STERLING BIOTECH
Dec-13
ABBOTT INDIA/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs6,11011 58,190.5%   
Low Rs3,9963 117,529.4%   
Sales per share (Unadj.) Rs1,552.226.8 5,790.5%  
Earnings per share (Unadj.) Rs188.8-15.0 -1,262.3%  
Cash flow per share (Unadj.) Rs196.4-5.5 -3,595.7%  
Dividends per share (Unadj.) Rs55.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs796.654.9 1,451.5%  
Shares outstanding (eoy) m21.25267.87 7.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.30.3 1,255.6%   
Avg P/E ratio x26.8-0.5 -5,759.6%  
P/CF ratio (eoy) x25.7-1.3 -2,022.0%  
Price / Book Value ratio x6.30.1 5,009.1%  
Dividend payout %29.10-   
Avg Mkt Cap Rs m107,3761,862 5,767.7%   
No. of employees `0003.31.4 245.3%   
Total wages/salary Rs m3,937547 720.0%   
Avg. sales/employee Rs Th9,929.35,303.3 187.2%   
Avg. wages/employee Rs Th1,185.1403.8 293.5%   
Avg. net profit/employee Rs Th1,207.7-2,959.0 -40.8%   
INCOME DATA
Net Sales Rs m32,9857,181 459.4%  
Other income Rs m1,17043 2,746.2%   
Total revenues Rs m34,1557,223 472.8%   
Gross profit Rs m5,245947 553.9%  
Depreciation Rs m1622,543 6.4%   
Interest Rs m384,377 0.9%   
Profit before tax Rs m6,215-5,931 -104.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203-1,924 -114.5%   
Profit after tax Rs m4,012-4,007 -100.1%  
Gross profit margin %15.913.2 120.6%  
Effective tax rate %35.432.4 109.2%   
Net profit margin %12.2-55.8 -21.8%  
BALANCE SHEET DATA
Current assets Rs m22,65514,335 158.0%   
Current liabilities Rs m6,68149,809 13.4%   
Net working cap to sales %48.4-494.0 -9.8%  
Current ratio x3.40.3 1,178.3%  
Inventory Days Days65403 16.1%  
Debtors Days Days29171 17.1%  
Net fixed assets Rs m83555,432 1.5%   
Share capital Rs m213268 79.3%   
"Free" reserves Rs m16,71513,935 119.9%   
Net worth Rs m16,92814,701 115.1%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m24,16273,988 32.7%  
Interest coverage x163.7-0.4 -46,115.2%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.40.1 1,406.6%   
Return on assets %16.80.5 3,346.7%  
Return on equity %23.7-27.3 -87.0%  
Return on capital %36.9-6.4 -574.9%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m3691,860 19.8%   
Fx outflow Rs m3,80725 15,293.6%   
Net fx Rs m-3,4381,835 -187.4%   
CASH FLOW
From Operations Rs m1,5271,719 88.8%  
From Investments Rs m-2,148-3,148 68.2%  
From Financial Activity Rs m-1,0241,426 -71.8%  
Net Cashflow Rs m-1,646-3 48,400.0%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.0 -  
FIIs % 0.1 9.9 1.0%  
ADR/GDR % 0.0 16.9 -  
Free float % 17.1 39.3 43.5%  
Shareholders   18,270 21,482 85.0%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   NOVARTIS  ASTRAZENECA PHARMA  DISHMAN PHARMA  IPCA LABS  NATCO PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 135 Points Lower; Realty and Telecom Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their trading session on a negative note.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY18); Net Profit Up 137.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 137.9% YoY). Sales on the other hand came in at Rs 8 bn (up 10.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

A 90% Chance of Auto Stocks Moving Up This April(Profit Hunter)

Apr 5, 2019

The Auto index ended on a positive note in the month of April in 9 out of last 10 years. This Auto stock is best placed to benefit from the upswing in this sector.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 18, 2019 03:37 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS